Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-056914

10% owner sold 3,124 shares at $29.06 ($90,783)

From the SEC's structured data for this filing

Trades in this filing

UBS Oncology Impact Fund L.P. · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-09-16 Sale : show line 1 in the form −3,124 $29.06 $90,783 7,648,268 D
Open-market sales · 3,124 sh · avg $29.06 · $90,783
Loading xslF345X03/doc4.xml…